Abogen Biosciences is based in Suzhou, China. It has raised $700M in total funding. Latest round: Series C.
Abogen Biosciences is based in Suzhou, China. Abogen Biosciences has raised $700M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series C announced in August 2021. The round record for Abogen Biosciences runs through 2021; nothing later has been disclosed. Investors on record include Temasek, Invesco Developing Markets Fund, Loyal Valley Capital, GL Ventures, Yunfeng Capital, Lilly Asia Ventures and 1 others. 7 distinct backers are named across the disclosed rounds.
Abogen Biosciences totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Suzhou below to benchmark round size and investor mix.
Company funding database · Investor directory · Founder database · Mega-rounds 2026